IP-10 decreases during antituberculous treatment in children with active tuberculosis
Conclusions: Our results demonstrate that IP-10 declines during anti-TB chemotherapy in childhood active TB and suggest it has the potential to become a biomarker for treatment monitoring in children.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Strzelak, A., Komorowska-Piotrowska, A., Borowa, A., Krasinska, M., Feleszko, W., Kulus, M. Tags: Tuberculosis Source Type: research